CN Stock MarketDetailed Quotes

600201 Jinyu Bio-Technology

Watchlist

6.84
+0.06+0.88%

Market Closed Nov 15 15:00 CST

7.66BMarket Cap46.53P/E (TTM)

Jinyu Bio-Technology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-29.07%1.28B

-32.05%1.31B

20.05%1.67B

21.83%1.71B

50.86%1.8B

62.33%1.92B

1.88%1.39B

5.34%1.41B

-26.03%1.19B

-17.67%1.18B

Transactional financial assets

-33.07%34.81M

-19.72%35.69M

2.65%45.63M

-20.59%37.27M

-55.62%52.02M

-68.52%44.45M

-69.29%44.45M

-74.47%46.94M

-49.98%117.2M

-51.12%141.21M

Notes receivable and accounts receivable

-20.65%751.65M

-13.12%711.96M

-15.68%773.28M

6.51%869.84M

9.08%947.26M

-0.64%819.51M

6.06%917.04M

9.93%816.65M

-0.71%868.37M

6.75%824.81M

-Notes receivable

-73.12%6.53M

-49.05%17.14M

-75.00%17.81M

-76.87%12.34M

-68.60%24.3M

-59.90%33.64M

96.08%71.23M

287.33%53.38M

26.31%77.4M

345.24%83.9M

-Accounts receivable

-19.27%745.12M

-11.59%694.82M

-10.68%755.47M

12.35%857.49M

16.69%922.95M

6.07%785.87M

2.12%845.8M

4.69%763.26M

-2.75%790.96M

-1.71%740.91M

Other receivables (including interest and dividends)

-1.42%39.53M

-14.00%44.49M

-46.62%39.52M

-30.89%33.66M

-26.48%40.1M

-23.47%51.73M

1.94%74.04M

28.73%48.7M

-4.59%54.55M

18.11%67.6M

-Other receivable

----

-14.00%44.49M

----

-23.47%51.73M

----

28.73%48.7M

----

18.11%67.6M

Advance payment

-1.88%28.5M

87.62%32.68M

16.69%24.75M

64.99%16.75M

43.67%29.05M

-0.94%17.42M

95.90%21.21M

4.34%10.15M

-35.23%20.22M

-44.20%17.59M

Inventories

-5.65%283.08M

-5.81%309.48M

-12.93%301.04M

-3.36%322.25M

-0.52%300.04M

-1.94%328.57M

4.16%345.74M

4.98%333.46M

-5.87%301.61M

-11.55%335.06M

Other current assets

54.27%32.66M

15.25%24.21M

12.47%24.16M

23.69%23.92M

-84.57%21.17M

-84.49%21M

-84.08%21.48M

-85.62%19.34M

1,144.35%137.17M

620.94%135.44M

Total current assets

-23.29%2.45B

-23.09%2.46B

2.27%2.88B

12.51%3.02B

18.49%3.19B

18.44%3.2B

-3.76%2.82B

-2.90%2.68B

-14.31%2.69B

-9.39%2.71B

Non Current assets

Other equity investment

474.96%257.19M

522.99%279.16M

522.27%278.7M

208.98%137.9M

28.43%44.73M

28.65%44.81M

28.43%44.79M

28.44%44.63M

-0.62%34.83M

-0.43%34.83M

Investment real estate

-3.55%97.52M

-3.52%98.42M

-3.49%99.32M

-3.46%100.22M

-3.43%101.12M

-3.40%102.02M

-3.37%102.91M

-3.35%103.81M

-3.32%104.71M

-3.29%105.61M

Long-term equity investment

-1.16%263.27M

-1.99%260.98M

-0.05%266.23M

-0.22%266.28M

-0.27%266.36M

-0.51%266.28M

-0.59%266.37M

-0.54%266.85M

1.31%267.09M

0.61%267.64M

Fixed assets

----

-3.49%1.52B

----

-6.05%1.58B

----

-2.55%1.64B

----

1.95%1.68B

Constru in process

----

65.35%331.85M

----

64.43%200.69M

----

17.85%151.72M

----

86.29%122.05M

Intangible assets

3.69%340.2M

7.29%350.27M

1.21%341.21M

1.38%352.12M

-8.78%328.11M

-10.60%326.46M

-10.78%337.14M

-10.59%347.32M

-8.84%359.69M

2.45%365.15M

Development expenditure

15.05%381.68M

9.17%373.1M

16.08%386.74M

17.29%376.71M

8.81%331.76M

21.09%341.75M

22.97%333.18M

23.51%321.19M

29.81%304.89M

13.39%282.23M

Goodwill

-61.31%11.41M

-68.80%29.49M

-29.61%94.5M

Long deferred expense

42.88%1.65M

47.40%1.79M

27.74%1.63M

5.58%1.41M

-17.02%1.16M

-17.86%1.21M

237.67%1.28M

1,224.43%1.34M

-73.02%1.39M

-71.82%1.48M

Deferred tax assets

3.36%87.63M

3.21%91.12M

14.84%96.29M

16.25%96.99M

-5.51%84.78M

-0.10%88.29M

-4.78%83.85M

-3.16%83.43M

3.78%89.73M

6.69%88.38M

Usufruct assets

55.86%7.95M

59.39%8.36M

62.13%8.84M

58.99%9.11M

-1.62%5.1M

-2.15%5.25M

-1.56%5.45M

0.25%5.73M

--5.19M

--5.36M

Other non current assets

84.25%1.16B

185.51%1.14B

2.12%672.21M

-12.69%621.22M

-10.69%626.9M

-46.00%398.75M

-11.09%658.22M

-9.31%711.51M

79.36%701.97M

79.18%738.37M

Total non current assets

23.46%4.45B

32.08%4.47B

11.01%4.04B

3.99%3.86B

-3.86%3.61B

-10.63%3.38B

-3.95%3.64B

-3.50%3.71B

10.00%3.75B

12.56%3.78B

Total assets

1.52%6.9B

5.24%6.93B

7.19%6.92B

7.56%6.87B

5.48%6.8B

1.49%6.59B

-3.87%6.46B

-3.25%6.39B

-1.66%6.45B

2.24%6.49B

Liabilities

Current liabilities

Short term loan

----

--10.01M

--60M

Notes payable and accounts payable

-21.84%267.81M

-25.10%252.82M

-17.70%307.1M

-8.46%324.41M

-3.02%342.65M

4.06%337.53M

-4.35%373.15M

2.12%354.41M

17.42%353.32M

22.37%324.38M

-Notes payable

13.44%40.72M

-27.02%28.13M

12.50%20.62M

41.31%18.26M

11.03%35.9M

230.91%38.54M

477.96%18.33M

146.38%12.92M

728.06%32.33M

--11.65M

-Accounts payable

-25.97%227.09M

-24.85%224.69M

-19.26%286.49M

-10.35%306.15M

-4.44%306.75M

-4.39%299M

-8.30%354.82M

-0.09%341.49M

8.08%320.99M

17.98%312.73M

Contract liabilities

-2.85%98.92M

1.61%106.9M

13.96%96.08M

15.42%97.7M

18.31%101.82M

3.05%105.2M

2.76%84.31M

2.54%84.65M

0.24%86.07M

8.07%102.08M

Advance receipts

----

--683.07K

----

Salaries payable

-29.20%27.42M

-25.07%27.57M

-14.00%30.73M

5.93%66.1M

-4.73%38.72M

7.36%36.79M

-0.78%35.73M

-8.53%62.4M

-10.57%40.65M

-8.27%34.27M

Taxs payable

-65.04%12.13M

-27.15%9.62M

43.34%26.65M

-36.92%18.06M

8.03%34.69M

-32.08%13.2M

-11.94%18.6M

42.10%28.64M

-17.22%32.11M

40.69%19.44M

Other payable (including interest and dividends)

-3.23%232.3M

34.16%316.71M

382.05%259.45M

311.30%269.07M

298.45%240.06M

35.79%236.07M

-58.24%53.82M

-51.06%65.42M

-65.12%60.25M

1.90%173.85M

-Interest payable

0.00%241.96K

-Dividend payable

----

7,359.55%89.37M

0.00%1.2M

-99.02%1.2M

-38.47%1.2M

814.52%122.26M

-Other payable

----

-3.21%227.1M

392.55%258.01M

318.30%267.63M

305.76%238.62M

356.96%234.63M

-58.65%52.38M

-51.34%63.98M

-65.52%58.81M

-67.30%51.35M

Non current liabilities due within one year

656.00%1.15M

348.04%1.17M

392.73%1.6M

186.58%1.53M

-51.76%152.41K

-44.81%260.05K

-47.33%325.19K

-13.44%534.45K

--315.95K

--471.19K

Other current liabilities

1.48%53.96M

5.73%55.75M

1.21%52.68M

19.38%62.89M

1.50%53.17M

-0.62%52.73M

-0.99%52.05M

42.78%52.68M

2,061.65%52.38M

1,790.40%53.06M

Total current liabilities

-14.49%693.69M

-1.44%770.53M

25.30%774.31M

27.58%840.45M

18.42%811.27M

1.85%781.79M

-14.33%617.99M

-4.41%658.75M

6.02%685.09M

31.40%767.55M

Current liabilities

Estimate liabilities

--268.29M

----

Deferred tax liabilities

-7.28%8.93M

-7.01%9.11M

-8.21%9.37M

-5.21%9.63M

-5.52%9.63M

-4.53%9.8M

-1.19%10.21M

-3.13%10.15M

-1.80%10.2M

-1.17%10.26M

Long term deferred income

5.08%380.81M

1.53%369.52M

-2.54%358.23M

-1.53%364.84M

3.22%362.41M

4.11%363.93M

8.17%367.55M

7.73%370.49M

9.35%351.09M

1.50%349.58M

Lease liabilities

973.26%2.24M

1,274.71%2.82M

798.19%2.79M

789.94%2.73M

--208.28K

--204.78K

86.64%311.15K

93.41%307.31K

----

Total non current liabilities

77.37%660.27M

73.76%649.74M

-2.03%370.39M

-0.99%377.2M

3.03%372.26M

3.92%373.93M

7.93%378.07M

7.45%380.95M

9.00%361.29M

1.43%359.84M

Total liabilities

14.40%1.35B

22.89%1.42B

14.92%1.14B

17.12%1.22B

13.11%1.18B

2.51%1.16B

-7.05%996.05M

-0.38%1.04B

7.03%1.05B

20.07%1.13B

Shareholders equity

Paid-in capital

0.00%1.12B

-0.52%1.12B

-0.00%1.13B

Capital reserve funds

-12.39%757.74M

-11.31%753.53M

8.20%902.75M

6.86%891.52M

3.66%864.86M

-4.90%849.58M

-6.61%834.3M

-8.25%834.3M

-0.99%893.34M

Surplus reserve funds

3.89%514.52M

6.98%495.23M

6.89%462.92M

Retained profit

1.80%3.24B

5.44%3.19B

6.39%3.26B

6.66%3.16B

6.33%3.18B

4.87%3.03B

2.80%3.07B

1.99%2.96B

0.79%2.99B

2.81%2.89B

Less:Treasury stock

-35.84%217.16M

0.00%338.48M

15.60%338.48M

15.28%338.48M

198.63%338.48M

96.14%292.81M

95.71%293.61M

Other composite income

5,310.09%12.76M

10,003.15%24.21M

13,925.65%23.76M

5,089.14%20.46M

-785.05%-244.82K

-480.85%-244.46K

-51.98%-171.83K

-76.22%-410.06K

-134.14%-27.66K

-474.01%-42.09K

Shareholders equity without minority interests

1.95%5.43B

4.53%5.39B

5.94%5.49B

5.81%5.37B

4.04%5.32B

1.54%5.16B

-3.25%5.18B

-3.79%5.07B

-3.24%5.12B

-0.85%5.08B

Minority interests

-58.55%121.06M

-55.66%122.07M

2.82%289M

3.82%288.06M

3.36%292.05M

-3.52%275.34M

-3.42%281.08M

-3.66%277.45M

-2.13%282.57M

-0.97%285.39M

Total shareholder equity

-1.19%5.55B

1.48%5.51B

5.78%5.78B

5.71%5.65B

4.00%5.62B

1.27%5.43B

-3.26%5.46B

-3.79%5.35B

-3.18%5.4B

-0.86%5.36B

Total liabilityies and equity

1.52%6.9B

5.24%6.93B

7.19%6.92B

7.56%6.87B

5.48%6.8B

1.49%6.59B

-3.87%6.46B

-3.25%6.39B

-1.66%6.45B

2.24%6.49B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Grant Thornton Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-29.07%1.28B	-32.05%1.31B	20.05%1.67B	21.83%1.71B	50.86%1.8B	62.33%1.92B	1.88%1.39B	5.34%1.41B	-26.03%1.19B	-17.67%1.18B
Transactional financial assets	-33.07%34.81M	-19.72%35.69M	2.65%45.63M	-20.59%37.27M	-55.62%52.02M	-68.52%44.45M	-69.29%44.45M	-74.47%46.94M	-49.98%117.2M	-51.12%141.21M
Notes receivable and accounts receivable	-20.65%751.65M	-13.12%711.96M	-15.68%773.28M	6.51%869.84M	9.08%947.26M	-0.64%819.51M	6.06%917.04M	9.93%816.65M	-0.71%868.37M	6.75%824.81M
-Notes receivable	-73.12%6.53M	-49.05%17.14M	-75.00%17.81M	-76.87%12.34M	-68.60%24.3M	-59.90%33.64M	96.08%71.23M	287.33%53.38M	26.31%77.4M	345.24%83.9M
-Accounts receivable	-19.27%745.12M	-11.59%694.82M	-10.68%755.47M	12.35%857.49M	16.69%922.95M	6.07%785.87M	2.12%845.8M	4.69%763.26M	-2.75%790.96M	-1.71%740.91M
Other receivables (including interest and dividends)	-1.42%39.53M	-14.00%44.49M	-46.62%39.52M	-30.89%33.66M	-26.48%40.1M	-23.47%51.73M	1.94%74.04M	28.73%48.7M	-4.59%54.55M	18.11%67.6M
-Other receivable	----	-14.00%44.49M	----	----	----	-23.47%51.73M	----	28.73%48.7M	----	18.11%67.6M
Advance payment	-1.88%28.5M	87.62%32.68M	16.69%24.75M	64.99%16.75M	43.67%29.05M	-0.94%17.42M	95.90%21.21M	4.34%10.15M	-35.23%20.22M	-44.20%17.59M
Inventories	-5.65%283.08M	-5.81%309.48M	-12.93%301.04M	-3.36%322.25M	-0.52%300.04M	-1.94%328.57M	4.16%345.74M	4.98%333.46M	-5.87%301.61M	-11.55%335.06M
Other current assets	54.27%32.66M	15.25%24.21M	12.47%24.16M	23.69%23.92M	-84.57%21.17M	-84.49%21M	-84.08%21.48M	-85.62%19.34M	1,144.35%137.17M	620.94%135.44M
Total current assets	-23.29%2.45B	-23.09%2.46B	2.27%2.88B	12.51%3.02B	18.49%3.19B	18.44%3.2B	-3.76%2.82B	-2.90%2.68B	-14.31%2.69B	-9.39%2.71B
Non Current assets
Other equity investment	474.96%257.19M	522.99%279.16M	522.27%278.7M	208.98%137.9M	28.43%44.73M	28.65%44.81M	28.43%44.79M	28.44%44.63M	-0.62%34.83M	-0.43%34.83M
Investment real estate	-3.55%97.52M	-3.52%98.42M	-3.49%99.32M	-3.46%100.22M	-3.43%101.12M	-3.40%102.02M	-3.37%102.91M	-3.35%103.81M	-3.32%104.71M	-3.29%105.61M
Long-term equity investment	-1.16%263.27M	-1.99%260.98M	-0.05%266.23M	-0.22%266.28M	-0.27%266.36M	-0.51%266.28M	-0.59%266.37M	-0.54%266.85M	1.31%267.09M	0.61%267.64M
Fixed assets	----	-3.49%1.52B	----	----	----	-6.05%1.58B	----	-2.55%1.64B	----	1.95%1.68B
Constru in process	----	65.35%331.85M	----	----	----	64.43%200.69M	----	17.85%151.72M	----	86.29%122.05M
Intangible assets	3.69%340.2M	7.29%350.27M	1.21%341.21M	1.38%352.12M	-8.78%328.11M	-10.60%326.46M	-10.78%337.14M	-10.59%347.32M	-8.84%359.69M	2.45%365.15M
Development expenditure	15.05%381.68M	9.17%373.1M	16.08%386.74M	17.29%376.71M	8.81%331.76M	21.09%341.75M	22.97%333.18M	23.51%321.19M	29.81%304.89M	13.39%282.23M
Goodwill	-61.31%11.41M	-61.31%11.41M	-61.31%11.41M	-61.31%11.41M	-68.80%29.49M	-68.80%29.49M	-68.80%29.49M	-68.80%29.49M	-29.61%94.5M	-29.61%94.5M
Long deferred expense	42.88%1.65M	47.40%1.79M	27.74%1.63M	5.58%1.41M	-17.02%1.16M	-17.86%1.21M	237.67%1.28M	1,224.43%1.34M	-73.02%1.39M	-71.82%1.48M
Deferred tax assets	3.36%87.63M	3.21%91.12M	14.84%96.29M	16.25%96.99M	-5.51%84.78M	-0.10%88.29M	-4.78%83.85M	-3.16%83.43M	3.78%89.73M	6.69%88.38M
Usufruct assets	55.86%7.95M	59.39%8.36M	62.13%8.84M	58.99%9.11M	-1.62%5.1M	-2.15%5.25M	-1.56%5.45M	0.25%5.73M	--5.19M	--5.36M
Other non current assets	84.25%1.16B	185.51%1.14B	2.12%672.21M	-12.69%621.22M	-10.69%626.9M	-46.00%398.75M	-11.09%658.22M	-9.31%711.51M	79.36%701.97M	79.18%738.37M
Total non current assets	23.46%4.45B	32.08%4.47B	11.01%4.04B	3.99%3.86B	-3.86%3.61B	-10.63%3.38B	-3.95%3.64B	-3.50%3.71B	10.00%3.75B	12.56%3.78B
Total assets	1.52%6.9B	5.24%6.93B	7.19%6.92B	7.56%6.87B	5.48%6.8B	1.49%6.59B	-3.87%6.46B	-3.25%6.39B	-1.66%6.45B	2.24%6.49B
Liabilities
Current liabilities
Short term loan	----	----	----	----	----	----	----	--10.01M	--60M	--60M
Notes payable and accounts payable	-21.84%267.81M	-25.10%252.82M	-17.70%307.1M	-8.46%324.41M	-3.02%342.65M	4.06%337.53M	-4.35%373.15M	2.12%354.41M	17.42%353.32M	22.37%324.38M
-Notes payable	13.44%40.72M	-27.02%28.13M	12.50%20.62M	41.31%18.26M	11.03%35.9M	230.91%38.54M	477.96%18.33M	146.38%12.92M	728.06%32.33M	--11.65M
-Accounts payable	-25.97%227.09M	-24.85%224.69M	-19.26%286.49M	-10.35%306.15M	-4.44%306.75M	-4.39%299M	-8.30%354.82M	-0.09%341.49M	8.08%320.99M	17.98%312.73M
Contract liabilities	-2.85%98.92M	1.61%106.9M	13.96%96.08M	15.42%97.7M	18.31%101.82M	3.05%105.2M	2.76%84.31M	2.54%84.65M	0.24%86.07M	8.07%102.08M
Advance receipts	----	----	----	--683.07K	----	----	----	----	----	----
Salaries payable	-29.20%27.42M	-25.07%27.57M	-14.00%30.73M	5.93%66.1M	-4.73%38.72M	7.36%36.79M	-0.78%35.73M	-8.53%62.4M	-10.57%40.65M	-8.27%34.27M
Taxs payable	-65.04%12.13M	-27.15%9.62M	43.34%26.65M	-36.92%18.06M	8.03%34.69M	-32.08%13.2M	-11.94%18.6M	42.10%28.64M	-17.22%32.11M	40.69%19.44M
Other payable (including interest and dividends)	-3.23%232.3M	34.16%316.71M	382.05%259.45M	311.30%269.07M	298.45%240.06M	35.79%236.07M	-58.24%53.82M	-51.06%65.42M	-65.12%60.25M	1.90%173.85M
-Interest payable	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K	0.00%241.96K
-Dividend payable	----	7,359.55%89.37M	0.00%1.2M	0.00%1.2M	0.00%1.2M	-99.02%1.2M	-38.47%1.2M	-38.47%1.2M	-38.47%1.2M	814.52%122.26M
-Other payable	----	-3.21%227.1M	392.55%258.01M	318.30%267.63M	305.76%238.62M	356.96%234.63M	-58.65%52.38M	-51.34%63.98M	-65.52%58.81M	-67.30%51.35M
Non current liabilities due within one year	656.00%1.15M	348.04%1.17M	392.73%1.6M	186.58%1.53M	-51.76%152.41K	-44.81%260.05K	-47.33%325.19K	-13.44%534.45K	--315.95K	--471.19K
Other current liabilities	1.48%53.96M	5.73%55.75M	1.21%52.68M	19.38%62.89M	1.50%53.17M	-0.62%52.73M	-0.99%52.05M	42.78%52.68M	2,061.65%52.38M	1,790.40%53.06M
Total current liabilities	-14.49%693.69M	-1.44%770.53M	25.30%774.31M	27.58%840.45M	18.42%811.27M	1.85%781.79M	-14.33%617.99M	-4.41%658.75M	6.02%685.09M	31.40%767.55M
Current liabilities
Estimate liabilities	--268.29M	--268.29M	----	----	----	----	----	----	----	----
Deferred tax liabilities	-7.28%8.93M	-7.01%9.11M	-8.21%9.37M	-5.21%9.63M	-5.52%9.63M	-4.53%9.8M	-1.19%10.21M	-3.13%10.15M	-1.80%10.2M	-1.17%10.26M
Long term deferred income	5.08%380.81M	1.53%369.52M	-2.54%358.23M	-1.53%364.84M	3.22%362.41M	4.11%363.93M	8.17%367.55M	7.73%370.49M	9.35%351.09M	1.50%349.58M
Lease liabilities	973.26%2.24M	1,274.71%2.82M	798.19%2.79M	789.94%2.73M	--208.28K	--204.78K	86.64%311.15K	93.41%307.31K	----	----
Total non current liabilities	77.37%660.27M	73.76%649.74M	-2.03%370.39M	-0.99%377.2M	3.03%372.26M	3.92%373.93M	7.93%378.07M	7.45%380.95M	9.00%361.29M	1.43%359.84M
Total liabilities	14.40%1.35B	22.89%1.42B	14.92%1.14B	17.12%1.22B	13.11%1.18B	2.51%1.16B	-7.05%996.05M	-0.38%1.04B	7.03%1.05B	20.07%1.13B
Shareholders equity
Paid-in capital	0.00%1.12B	0.00%1.12B	0.00%1.12B	0.00%1.12B	0.00%1.12B	-0.52%1.12B	-0.52%1.12B	-0.52%1.12B	-0.52%1.12B	-0.00%1.13B
Capital reserve funds	-12.39%757.74M	-11.31%753.53M	8.20%902.75M	6.86%891.52M	3.66%864.86M	-4.90%849.58M	-6.61%834.3M	-6.61%834.3M	-8.25%834.3M	-0.99%893.34M
Surplus reserve funds	3.89%514.52M	3.89%514.52M	3.89%514.52M	3.89%514.52M	6.98%495.23M	6.98%495.23M	6.98%495.23M	6.98%495.23M	6.89%462.92M	6.89%462.92M
Retained profit	1.80%3.24B	5.44%3.19B	6.39%3.26B	6.66%3.16B	6.33%3.18B	4.87%3.03B	2.80%3.07B	1.99%2.96B	0.79%2.99B	2.81%2.89B
Less:Treasury stock	-35.84%217.16M	-35.84%217.16M	0.00%338.48M	0.00%338.48M	15.60%338.48M	15.28%338.48M	198.63%338.48M	198.63%338.48M	96.14%292.81M	95.71%293.61M
Other composite income	5,310.09%12.76M	10,003.15%24.21M	13,925.65%23.76M	5,089.14%20.46M	-785.05%-244.82K	-480.85%-244.46K	-51.98%-171.83K	-76.22%-410.06K	-134.14%-27.66K	-474.01%-42.09K
Shareholders equity without minority interests	1.95%5.43B	4.53%5.39B	5.94%5.49B	5.81%5.37B	4.04%5.32B	1.54%5.16B	-3.25%5.18B	-3.79%5.07B	-3.24%5.12B	-0.85%5.08B
Minority interests	-58.55%121.06M	-55.66%122.07M	2.82%289M	3.82%288.06M	3.36%292.05M	-3.52%275.34M	-3.42%281.08M	-3.66%277.45M	-2.13%282.57M	-0.97%285.39M
Total shareholder equity	-1.19%5.55B	1.48%5.51B	5.78%5.78B	5.71%5.65B	4.00%5.62B	1.27%5.43B	-3.26%5.46B	-3.79%5.35B	-3.18%5.4B	-0.86%5.36B
Total liabilityies and equity	1.52%6.9B	5.24%6.93B	7.19%6.92B	7.56%6.87B	5.48%6.8B	1.49%6.59B	-3.87%6.46B	-3.25%6.39B	-1.66%6.45B	2.24%6.49B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

600201 Jinyu Bio-Technology

Jinyu Bio-Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target